Press Release

Cord Blood America Announces CorCell, Highmark Marketing Alliance

Los Angeles, CA and Philadelphia, PA (December 14, 2006) – Cord Blood America, Inc. (OTC BB: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that CorCell, Philadelphia, Pa., whose operating entity and assets were recently purchased by the Company, has entered into a marketing alliance with Highmark Inc., the largest Pennsylvania health insurer based on membership and one of the largest health insurers in the U.S.

"The alliance brings the knowledge and awareness of the significant value of storing umbilical cord blood to Highmark members, providers and employer groups," said Marcia Laleman, CorCell's President. "Highmark selected CorCell as a strategic value added program and CorCell will offer Highmark members a preferred price for the cord blood banking service."

CorCell is a national leader in private family cord blood banking. It is the fourth largest private umbilical cord blood bank in the U.S.

"Cord blood stem cells may be used today to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies with many additional uses currently under investigation in clinical trials. Previously the umbilical cord, which contains a rich store of stem cells, had been thrown away at birth," Ms. Laleman said.

"We are pleased to work with CorCell to enable our members to take advantage of this service," said Carey Vinson, M.D., Highmark's vice president of Quality and Medical Performance Management. "This program is another way Highmark enables its members to have a greater hand in their health."

CorCell offers cord blood banking services directly to Highmark members. Highmark markets the service to its members through educational materials and mailings. "Cord Blood America is delighted to announce this new initiative and is looking forward to the value it will bring to both Highmark members and our shareholders," said Matthew Schissler, CEO of Cord Blood America, Inc.

About Cord Blood America
Cord Blood America (OTC BB:CBAI.OB -News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. For investor information on Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit www.cordblood-america.com.

Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as “anticipate,” “believe,” “expect,” “future,” “intend,” “plan,” and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company’s performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company’s public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company’s past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

Read more Press Releases by following this link: CorCell Cord Blood Bank News.